rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-6-19
|
pubmed:abstractText |
The Bard BTA test has been shown in early studies to be useful in diagnosing transitional cell carcinoma (TCC) of the bladder. However, the utility of this test has not been evaluated for TCC of the upper urinary tract. We therefore evaluated the clinical utility of the BTA test for upper urinary TCC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0090-4295
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
956-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9609633-Carcinoma, Transitional Cell,
pubmed-meshheading:9609633-False Negative Reactions,
pubmed-meshheading:9609633-False Positive Reactions,
pubmed-meshheading:9609633-Humans,
pubmed-meshheading:9609633-Kidney Neoplasms,
pubmed-meshheading:9609633-Kidney Pelvis,
pubmed-meshheading:9609633-Latex Fixation Tests,
pubmed-meshheading:9609633-Predictive Value of Tests,
pubmed-meshheading:9609633-Sensitivity and Specificity,
pubmed-meshheading:9609633-Ureteral Neoplasms
|
pubmed:year |
1998
|
pubmed:articleTitle |
Utility of the Bard BTA test in detecting upper urinary tract transitional cell carcinoma.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, University of Pennsylvania Health System, Philadelphia 19104-2699, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|